Pentixapharm
PTPCompletedEURadiopharmaceutical biotech developing CXCR4-targeted diagnostics/therapeutics (PentixaFor/PentixaTher).
- Distribution date
- 3 Oct 2024
- Structure
- Spin-off
- Parent
- Eckert & Ziegler (EUZ)
- Spin-off ticker
- PTP
- Listing
- Frankfurt (Prime Standard)
- Market
- Europe
- Size
- EUR 126.5m market cap at first listing (first price EUR 5.10)
Source documents
- Press releasePentixapharm Holding: IPO and listing in Prime Standard (10/03/24)
- PresentationNot located
- Prospectus / demerger documentNot located
- Source4investors.de
- Sourceheuking.de
- Sourcelive.deutsche-boerse.com
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email